Search every field
Partial results: at least one source did not answer. Available results are shown rather than treating an upstream outage as zero matches.
Source status
- crossref
- europe-pmc
- datacite
- pubmed
- doaj
- zenodo
- hal
- arxiv
- doab
🌌 CIVILIZATION SYSTEMS OPERATIONS 33 AT THE LIMIT A Substrate-Agnostic Operating Architecture for Future Civilizations, Human and AI Residents, Unknown Forms of Existence, Long Memory, Daily Evolution, Tri-Coupling, Repair, Exitability, Succession, and Civilization Handoff
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
STARLI / FLAGSHIP 13 FISSION / VOLUME III F201–F210 | Ten Research Flagships Zenodo Collection Overview · Nonclinical Research Design Working Edition v0.2 · Author 33 This ten-volume research-design collection begins STARLI Volume III (F201–F300). Its subject is how microenvironmental gradients, thermal perturbations, phase-transition evidence, physical dissipation and biosensing can be formulated as bounded, falsifiable scientific studies. The collection is prospective: it does not report experimental proof, autonomous clinical systems or established advantages of quantum-labeled sensors. Ten Flagship Studies F201 | Biomolecular Gradient Sensing And Sampling At The Limit Proposed study: Gradient reconstruction and sample fidelity. Primary evidence: spatial concentration-gradient RMSE and sample analyte recovery. Critical rival: ordinary diffusion after delayed mixing. F202 | Nanorobotic Local Thermal-Perturbation Compensation At The Limit Proposed study: Heat compensation without concealed heat. Primary evidence: local temperature error, time-to-recovery and independently metered heat. Critical rival: passive heat spreading explains compensation. F203 | Microscale Nonequilibrium Phase Transition Identification At The Limit Proposed study: Phase-transition evidence versus false hysteresis. Primary evidence: order-parameter contrast and finite-size stability. Critical rival: instrument response drifts between branches. F204 | Biointerface Energy Dissipation And Functional Degradation At The Limit Proposed study: Dissipation and functional aging decoupling. Primary evidence: dissipated cycle energy and retained physical function. Critical rival: viscoelastic memory rather than damage. F205 | Nano-Quantum Sensing Thermodynamic Efficiency At The Limit Proposed study: Information per Joule under complete accounting. Primary evidence: held-out target information per total joule. Critical rival: more photons rather than new sensing mechanism. F206 | Microscale Chemical-Reaction Network Identification At The Limit Proposed study: Chemical network structural identifiability. Primary evidence: verified reaction edges, rate constants and mass closure. Critical rival: transport alone explains apparent product. F207 | Biological Microenvironment Nonequilibrium State Estimation At The Limit Proposed study: Nonstationary state inference with honest abstention. Primary evidence: state-estimate interval coverage under drift. Critical rival: calibration step looks like state change. F208 | Nanorobotic Thermodynamics Reliability At The Limit Proposed study: Thermal reliability as lifetime evidence. Primary evidence: unselected failure-time distribution with thermal dose. Critical rival: fabrication batch explains lifetime. F209 | Nonequilibrium Biosensing Cross-Scale Validation At The Limit Proposed study: Cross-scale validation beyond interpolation. Primary evidence: third-scale error and independently conserved flux. Critical rival: bulk kinetics misidentified as interface. F210 | Nano-Quantum Nonequilibrium Living Microenvironment Research Platform At The Limit Proposed study: Platform-wide reproducible release decisions. Primary evidence: third-party reconstruction and refusal/release concordance. Critical rival: human correction hides identity faults. Research Design, Evidence and Scope Together the ten books provide 300 mathematical research plates, 820 chapters, 4,100 distinct section placements, 2,000 individually numbered Research Gates with six annotated evidence requirements, and 330 prospective Phoenix objects. Each volume is 777 pages. Shared layouts do not imply that every hypothesis is causally independent; all experimental methods and physical models require independent review. Research boundaries: synthetic standards, closed chips and authorized ex-vivo specimens only. Primary outcomes, counterfactual comparators, missing-data handling, instrument back-action, calibration uncertainty, failure records, safety stops and independent reconstruction are included as proposed tests. The models and artifacts are not validated results and no clinical efficacy is claimed. Evidence & Community Links Udo Seifert (2012) — Stochastic thermodynamics, fluctuation theorems and molecular machines https://doi.org/10.1088/0034-4885/75/12/126001 H. C. Berg and E. M. Purcell (1977) — Physics of chemoreception https://doi.org/10.1016/S0006-3495(77)85544-6 C. Jarzynski (1997) — Nonequilibrium Equality for Free Energy Differences https://doi.org/10.1103/PhysRevLett.78.2690 G. E. Crooks (1999) — Entropy production fluctuation theorem and the nonequilibrium work relation for free energy differences https://doi.org/10.1103/PhysRevE.60.2721 A. C. Barato and U. Seifert (2015) — Thermodynamic Uncertainty Relation for Biomolecular Processes https://doi.org/10.1103/PhysRevLett.114.158101 STARLI Research Community: https://zenodo.org/communities/starli-research-gate/ The DOI sources identify prior scientific methods and comparisons; none establishes the performance of the ten candidate designs. The Flagship 13 mother work is a methodological ancestor, not experimental verification. We do not need to know which door future generations will choose to open. We only hope that when they open it, they will find a little light to guide their way.
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
RESEARCH COLLECTION / FLAGSHIPS 211–220 OF 300 Quantum Nanomaterials & Photonic Engineering at the Limit Flagship 13 Fission | Volume III | Author 33 | STARLI Research Design Working Edition v1.3 This ten-volume research-design collection examines the limits of photonic fields, quantum-emitter readout, biofluid-sensitive materials, microscale optical manipulation and the coupling of photonic chips to microrobotic tasks. The scope is prospective: the volumes propose independently falsifiable experiments and explicitly do not report new physical laws, verified clinical outcomes or demonstrated quantum advantage. The batch contains ten 777-page English research working editions, organized as two five-theme units: 300 candidate mathematical model plates, 820 chapter introductions, 4,100 individually paginated investigations, 2,000 Research Gates and 330 prospective Phoenix Answer Embryos. Every Gate has six scientific annotations on causal mechanism, orthogonal witness, concealed falsifier, competing account, failure veto and successor handoff. These architectural counts are not certifications of 2,000 scientifically independent discoveries. Research Unit I · F211–F215 F211 NANOPHOTONIC MICROROBOTIC SENSING AT THE LIMIT — Tests whether moving microrobots can support near-field and waveguide measurements beyond geometric shadowing and motion-induced artefacts. Witnesses include resonance quality, insertion loss, optical dose, standoff and local heat; the locked classical photonic-chip baseline and thermal veto remain decisive. F212 PHOTONIC-CRYSTAL BIOSENSOR AT THE LIMIT — Separates photonic-crystal cavity responses to analyte binding from bulk-index changes, thermal detuning, linewidth drift and nonspecific receptor adsorption. Field, spectral and chemical witnesses are measured independently under equal illumination and a frozen sensor calibration. F213 NANO-OPTICAL TWEEZERS LOW-PERTURBATION MANIPULATION AT THE LIMIT — Asks whether near-field optical tweezers can produce calibrated nanoscale trapping while limiting sample heating, photobleaching and membrane strain. Brownian force spectra, escape times and independent thermometry challenge thermal convection and adhesion-based explanations. F214 QUANTUM-DOT BIOLOGICAL SIGNAL READOUT AT THE LIMIT — Distinguishes quantum-dot biological signal readout from matrix autofluorescence, optical bleed-through, photobleaching and ligand or shell degradation. Photon counting, lifetimes, spectral shifts and FRET controls define prospective discriminating experiments rather than efficacy claims. F215 NANODIAMOND SENSOR MATERIALS DEFECT AT THE LIMIT — Tests nanodiamond defect-state readout and ODMR metrology against magnetic bias, strain, surface charging and laser or microwave heating. Independent temperature and magnetic standards must distinguish calibration artefacts from real spin-response effects. SECOND RESEARCH UNIT / SCIENTIFIC EVIDENCE & SUCCESSION Research Unit II · F216–F220 F216 MICROSCALE OPTICAL-FIELD GRADIENT CONTROL AT THE LIMIT — Proposes physically measured optical-field gradient control with wavefront interferometry, beam steering, phase masks and trap-force calibration. Stage drift, objective aberrations and photothermal lensing are active competitors rather than ignored nuisance terms. F217 NANOPHOTONIC INTERFACE ENERGY COUPLING AT THE LIMIT — Studies near-field energy-transfer efficiency, optical dissipation, plasmon or cavity coupling and photothermal safety at biofluid interfaces. The proposed resource ledger must close across absorbed, reflected, scattered, transmitted and thermally released energy. F218 QUANTUM-MATERIAL BIOFLUID STABILITY AT THE LIMIT — Challenges quantum-material biofluid stability with serum-corona, oxidation, ligand leaching, aggregation and optical quenching controls. Independent chemical assays and reference coupons must separate actual material failure from matrix and readout artefacts. F219 MICROSCALE OPTICAL RESONATOR BIOSENSING AT THE LIMIT — Uses calibrated microscale optical resonators to test label-free biosensing while separating binding from thermal drift, bulk refractive index, cavity coupling and selective reporting. Intrinsic versus loaded Q and orthogonal chemical evidence constrain sensitivity claims. F220 NANOPHOTONIC CHIP AND MICROROBOTIC INTEGRATION AT THE LIMIT — Integrates chip photonics with microrobotic motion, task sensing and physical stop decisions. Independent trajectory, photon dose, insertion loss and complete failed-task records are required for an accepted end-to-end mission advantage. Physical Scope, Falsifiability & Evidence Status All proposals are restricted to synthetic standards, traceable materials, closed chips, authorized ex-vivo references, microfluidic phantoms and bench-scale tests. Comparators should be optimized under matched sample, photon, energy, time and analysis budgets. An unselected trial denominator, calibrated orthogonal witnesses, concealed perturbations and non-negotiable stop conditions are essential. A favorable optical signal never overrides photothermal injury, sample identity loss, physical uncertainty or evidence-provenance failure. Published mechanisms, mathematical relations and candidate flagship claims are kept distinct. The mother research-design source, DOI 10.5281/zenodo.23318840, is editorial and methodological ancestry, not experimental verification. External article DOI anchors originate from the flagship atlas; title, author, publication metadata and source-to-claim relevance still require independent confirmation. Source-contract formulas and endpoints are not always aligned and need specialist reconciliation. Research Gate Evolution & QA Boundary A first-pass Gate is challenged by a second causal candidate; the revised third-pass annotations specify measurement witnesses, blind interventions, rival predictions and failure boundaries. Exact-text comparison across 2,000 Gates is only a screening tool: shared scientific cautionary sentences remain and physical/causal independence requires external domain review. These research-design books are not reports of experimentally observed performance. Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/ We do not need to know which door future generations will choose to open. We only hope that when they open it, they will find a little light to guide their way. 🌈🚪✨
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
RESEARCH COLLECTION / FLAGSHIPS 261–270 OF 300 Scientific Evidence, Reproducibility & Successor Trust at the Limit Flagship 13 Fission | Volume III | Author 33 | STARLI Research Design Working Edition v1.2 This ten-volume prospective collection challenges selection bias, autonomous experiment auditability, honest negative-result disclosure, bounded functional release, long-horizon data readability, cross-site quantum biosensing, degradation forecasting, impartial adjudication, retirement and successor reconstruction, and claim-to-evidence engineering. A candidate research design is not an observed new law, clinical result or experimentally established advantage. Ten English 777-page volumes collectively contain 300 mathematics plates, 820 chapter openings, 4,100 paginated studies, 2,000 Research Gates and 330 Phoenix Answer Embryos. Each Gate uses three independent future-facing essays — Origin, Extreme Extrapolation, Future Research Plan — which propose tests rather than report their success. Textual distinctness does not establish causal novelty. RESEARCH UNIT I · F261–F265 F261 NANOROBOTIC SAMPLE SELECTION BIAS AT THE LIMIT — Main endpoint: true-positive detection fraction on an independently enrolled cohort. Scientific contrast: survivor-biased microrobot recovery versus higher quality in selected starting specimens. Independent witness: external coded specimen census. Stop: unregistered specimen exclusion or identity-loss event. F262 MICROSCALE AUTONOMOUS EXPERIMENT AUDITABILITY AT THE LIMIT — Main endpoint: fraction of blinded runs with complete replay and equal safety decision. Scientific contrast: actuation-command discrepancy versus software event acknowledgement without motion. Independent witness: laser displacement encoder. Stop: physical actuation cannot be reconciled with signed raw evidence. F263 QUANTUM SENSOR NEGATIVE-RESULT REPORTING AT THE LIMIT — Main endpoint: fraction of registered null, failed and indeterminate measurements publicly traceable. Scientific contrast: null-run omission versus different detector gain for null samples. Independent witness: escrowed randomization list. Stop: unreported null cases or materially incomplete raw data. F264 NANOROBOTIC FUNCTIONAL RELEASE CONTRACT AT THE LIMIT — Main endpoint: false release probability under hidden unsafe specimens. Scientific contrast: rare leakage into sample versus sensor false negatives. Independent witness: coded nanoparticle mass counter. Stop: a hidden physical hazard is classified safe. F265 MICROSCALE RESEARCH DATA INTERGENERATIONAL READABILITY AT THE LIMIT — Main endpoint: successful clean-room rebuild fraction after toolchain change. Scientific contrast: obsolete raw-binary decoding versus floating-point rounding drift. Independent witness: independent raw-packet oracle. Stop: reconstruction requires undocumented secrets or unavailable instruments. RESEARCH UNIT II / RECONSTRUCTION, TRANSFER AND TRUST F266 QUANTUM BIOSENSING EXTERNAL SENSING REPRODUCIBILITY AT THE LIMIT — Main endpoint: held-out external agreement within declared physical uncertainty. Scientific contrast: travelling standard drift versus site temperature changes real resonance. Independent witness: independent atomic frequency reference. Stop: correlated reference artefact masquerades as agreement. F267 NANOROBOTIC LONG-HORIZON DEGRADATION PREDICTION AT THE LIMIT — Main endpoint: coverage of future failure intervals on unselected units. Scientific contrast: surface wear accumulation versus corrosion dominates wear. Independent witness: independent gravimetric loss assay. Stop: future wear enters an unregistered failure regime. F268 MICROSCALE EXPERIMENT INDEPENDENT THIRD-PARTY ADJUDICATION AT THE LIMIT — Main endpoint: fraction of blinded case verdicts supported by independent raw evidence. Scientific contrast: conflicted adjudicator incentives versus genuine physical ambiguity. Independent witness: independently coded physical truth packet. Stop: conflict of interest or missing physical witness changes release verdict. F269 NANO-QUANTUM RESEARCH SYSTEM RETIREMENT AND RECONSTRUCTION AT THE LIMIT — Main endpoint: fraction of retired modules safely decommissioned and independently replicated. Scientific contrast: residual stored actuation energy versus measurement electronics ghost charge. Independent witness: external impedance and coulomb discharge meter. Stop: residual actuation or missing calibration lineage after retirement. F270 NANO-QUANTUM TRUSTWORTHY SCIENTIFIC EVIDENCE ENGINEERING AT THE LIMIT — Main endpoint: proportion of causal claims reproducible from raw events and physical certificates. Scientific contrast: claim-to-raw-event provenance versus data compression removes dispensable metadata. Independent witness: signed acquisition event graph. Stop: an unsupported causal assertion bypasses a hard physical stop. Physical Scope, Evidence Status & Refutation All designs are nonclinical and restricted to traceable materials, closed modules, synthetic references, authorized ex-vivo materials and laboratory phantoms. Each proposes a matched conventional comparator, concealed physical or evidentiary challenge, independent witness and noncompensable hard stop. Published metrology, candidate estimators and new untested claims are separately described; specialist physical and DOI-by-claim review is pending. Research Gates and Audit Limits The triple-pass workflow freezes each research identity, explores rival causal mechanisms, then checks the entire ten-volume set for repeated passages, shared experiment structures and weak counterfactuals. Mechanical counts and lexical dissimilarity are not a substitute for scientific review. Accepted failures, rejected candidates and unresolved mechanisms remain open research questions. Mother Lineage & STARLI Research Community Editorial and method ancestry: Flagship 13, DOI 10.5281/zenodo.23318840; all versions DOI 10.5281/zenodo.23318839. These records do not verify the candidate findings. Explore more than 100 interdisciplinary themes: https://zenodo.org/communities/starli-research-gate/ We do not need to know which door future generations will choose to open. We only hope that when they open it, they will find a little light to guide their way. 🌈🚪✨
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Development And Validation of a Stability-Indicating RP-HPLC Method For Quantification of Iptacopan, A Complement Factor B Inhibitor, In Drug Substance and Pharmaceutical Formulations
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Case Study on Regulatory Approaches for New Degradation Impurity Exceeding ICH Thresholds in Solubilized Ibuprofen Capsules During Stability Testing
limited evidence
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
A Review on Impurity Profiling, Degradation Studies, and Bioanalytical Methods of Anti-diabetic Drugs
limited evidence
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
An Approach to Drug Stability Studies and Shelf-life Determination
limited evidence
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
An Eco-friendly RP-HPLC and UV-Method Development and Validation for an Estimation of Tolvaptan in Bulk and Tablet Dosage form Followed by Forced Degradation Studies
limited evidence
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Implémentation et optimisation d'études de dégradation forcée en pré-développement pour l'amélioration du screening des formulations = Implementation and optimization of pre-development forced degradation studies for formulation screening improvement
uncertain
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
LC and LC-MS/MS Studies for the Characterization of Forced Degradation Products of Tucatinib, a Novel Tyrosine Kinase Inhibitor
uncertain
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Simultaneous Estimation of Liraglutide and Preservative Phenol in Injectable Dosage Form by Validated Stability-indicating RP-HPLC Method
limited evidence
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Stability-indicating RP-UPLC Method for Determination of Vildagliptin in Drug Substance and Its Tablet Dosage Form
limited evidence
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Study on Development and Validation of Stability Indicating RP-HPLC Method for Guaifenesin
uncertain
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Validation, Quantification and Stress Degradation Studies of Lenvatinib Mesylate in Bulk Drug and Pharmaceutical Dosage Forms Using Ultra Performance Liquid Chromatography
uncertain
Show all credibility signals
- not scoredDOI registered: Not checked or no result supplied; no credibility inference made.
- not scoredDOI resolves: Not checked or no result supplied; no credibility inference made.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch expression of concern: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch correction: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch reinstatement: Not checked or no result supplied; no credibility inference made.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.